Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 2
1989 2
1991 1
1992 3
1993 2
1994 1
1995 1
1996 2
1997 1
1998 1
1999 1
2001 1
2005 1
2006 1
2007 2
2009 2
2010 5
2011 3
2012 2
2013 7
2014 9
2015 10
2016 7
2017 4
2018 2
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26886900

71 results

Results by year

Filters applied: . Clear all
Page 1
Radiosensitization by BRAF inhibitors.
Strobel SB, Pätzold S, Zimmer L, Jensen A, Enk A, Hassel JC. Strobel SB, et al. J Dtsch Dermatol Ges. 2017 Jul;15(7):703-708. doi: 10.1111/ddg.12672. Epub 2017 May 30. J Dtsch Dermatol Ges. 2017. PMID: 28557366
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ, Amonkar MM, Karaszewska B, Schachter J, Dummer R, Mackiewicz A, Stroyakovskiy D, Drucis K, Grange F, Chiarion-Sileni V, Rutkowski P, Lichinitser M, Levchenko E, Wolter P, Hauschild A, Long GV, Nathan P, Ribas A, Flaherty K, Sun P, Legos JJ, McDowell DO, Mookerjee B, Schadendorf D, Robert C. Grob JJ, et al. Lancet Oncol. 2015 Oct;16(13):1389-98. doi: 10.1016/S1470-2045(15)00087-X. Lancet Oncol. 2015. PMID: 26433819 Clinical Trial.
Dabrafenib Active in Rare NSCLC Subtype.
[No authors listed] [No authors listed] Cancer Discov. 2016 Jul;6(7):OF4. doi: 10.1158/2159-8290.CD-NB2016-062. Epub 2016 May 20. Cancer Discov. 2016. PMID: 27207893
[Radiation recall dermatitis after oral cyclophosphamide].
Mievis C, Jansen N, Schleich F, Gennigens C, Rorive A, Jérusalem G, Fillet G, Sautois B. Mievis C, et al. Rev Med Liege. 2009 Apr;64(4):179-81. Rev Med Liege. 2009. PMID: 19514535 Free article. French.
Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).
O'Brien ME, Gaafar R, Hasan B, Menis J, Cufer T, Popat S, Woll PJ, Surmont V, Georgoulias V, Montes A, Blackhall F, Hennig I, Schmid-Bindert G, Baas P; EORTC-LCG. O'Brien ME, et al. Eur J Cancer. 2015 Aug;51(12):1511-28. doi: 10.1016/j.ejca.2015.04.026. Epub 2015 Jun 11. Eur J Cancer. 2015. PMID: 26074395 Free article. Clinical Trial.
Vemurafenib/dabrafenib and trametinib.
Rissmann R, Hessel MH, Cohen AF. Rissmann R, et al. Br J Clin Pharmacol. 2015 Oct;80(4):765-7. doi: 10.1111/bcp.12651. Epub 2015 Jun 11. Br J Clin Pharmacol. 2015. PMID: 25847075 Free PMC article. No abstract available.
Improved overall survival in melanoma with combined dabrafenib and trametinib.
Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L, Chiarion-Sileni V, Drucis K, Krajsova I, Hauschild A, Lorigan P, Wolter P, Long GV, Flaherty K, Nathan P, Ribas A, Martin AM, Sun P, Crist W, Legos J, Rubin SD, Little SM, Schadendorf D. Robert C, et al. N Engl J Med. 2015 Jan 1;372(1):30-9. doi: 10.1056/NEJMoa1412690. Epub 2014 Nov 16. N Engl J Med. 2015. PMID: 25399551 Free article. Clinical Trial.
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment.
Nakashima K, Saruwatari K, Sato R, Imamura K, Kajihara I, Fukushima S, Saito T, Ishizuka S, Tamanoi D, Jodai T, Hamada S, Tomita Y, Saeki S, Ichiyasu H, Oya N, Ihn H, Sakagami T. Nakashima K, et al. Intern Med. 2020 May 1;59(9):1199-1202. doi: 10.2169/internalmedicine.3937-19. Epub 2020 Feb 12. Intern Med. 2020. PMID: 32051381 Free PMC article.
71 results